Author

Patrick Bednarz

Rice University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1 Organism:non-human primate· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

Amir ArdeshiriD· 1 shared Anthony E. DavisiD· 1 shared Chancellor SmithiD· 1 shared Christy L. LavineiD· 1 shared Cody FelliD· 1 shared Danna MurungiiD· 1 shared Erin Haupt· 1 shared Imaan MohandessiiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

Amir ArdeshirORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Once yearly cell-based therapy for sustained and dose tunable delivery of monoclonal antibodies

Cody Fell, Anthony E. Davis, Shalini Pandey, Michael Tyler Guinn, Zeshi Wang, Jonathon DeBonis, Chancellor Smith, Nathan Brown, Danna Murungi, 김연주, Imaan Mohandessi, Patrick Bednarz, Amir Ardeshir, Erin Haupt, Samuel Cuevas, , Omid Veiseh A

This paper develops a cell-based therapy that enables sustained, dose-tunable delivery of monoclonal antibodies through a single administration, demonstrating long-term efficacy and safety in preclinical models.

Science Advances · Oct 2, 2026Peer-reviewedBioengineering